Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival

Technology in Cancer Research & Treatment
Zhuhui YuanWei Li

Abstract

This study aimed to evaluate the efficacy of percutaneous thermal ablation combined with transarterial embolization for recurrent hepatocellular carcinoma after hepatectomy and establish a prognostic nomogram to predict survival. One hundred seventeen patients with recurrent hepatocellular carcinoma receiving ablation from 2009 to 2014 were included in primary cohort to establish a prognostic nomogram. Between 2014 and 2016, 51 patients with recurrent hepatocellular carcinoma treated by ablation were enrolled in the validation cohort to validate the predictive accuracy of the nomogram. All patients underwent locoregional ablation. Overall survival was the primary end point, and progression-free survival was the second end point. The performance of the nomogram was assessed through concordance index and calibration curve and compared with 5 conventional hepatocellular carcinoma staging systems. The 1-, 3-, and 5-year overall survival rates of primary cohort were 88.4%, 70.7%, and 64.1%, respectively. The 1-, 3-, and 5-year progression-free survival rates of primary cohort were 44%, 14%, and 8.7%, respectively. The results of multivariate analysis showed that tumor size ( P = .0469; hazard ratio, 1.020; 95% confidence interval, 1...Continue Reading

References

Jul 31, 1998·Journal of Hepato-biliary-pancreatic Surgery·E RegaliaV Mazzaferro
Sep 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Oct 13, 1999·Seminars in Liver Disease·J M LlovetJ Bruix
Nov 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M LlovetJ Bruix
May 9, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S JonasP Neuhaus
Sep 30, 2003·Journal of Vascular and Interventional Radiology : JVIR·Reed A OmaryUNKNOWN Society of Interventional Radiology Standards of Practice Committee
Oct 28, 2003·Annals of Surgery·Masami MinagawaNorihiro Kokudo
Dec 24, 2005·Journal of Vascular and Interventional Radiology : JVIR·Christos S GeorgiadesJean-Francois H Geschwind
Mar 31, 2007·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Jeremy R ParfittDavid K Driman
Feb 23, 2010·Seminars in Liver Disease·Alejandro FornerJordi Bruix
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Sep 24, 2011·European Journal of Gastroenterology & Hepatology·Yen-Huai LinCheng-Yen Chang
Oct 5, 2011·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Cun LiuChangchun Liu
Oct 14, 2011·The New England Journal of Medicine·Hashem B El-Serag
Feb 23, 2012·Lancet·Alejandro FornerJordi Bruix
Sep 5, 2014·Annals of Surgery·Yoshihiro MiseNorihiro Kokudo
Oct 7, 2014·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Wing Chiu DaiRonnie T P Poon
Dec 2, 2014·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·K WangF Shen

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
CLIP

Software Mentioned

R
cens
rcorrp
Hmisc

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.